Wall Street Breakfast Podcast: Bitcoin's Great Withdrawal
Bitcoin is currently underperforming compared to equities, facing significant ETF outflows and reduced institutional interest. The recent sale of Bitcoin by MSTR after nearly four years raises concerns about their long-term strategy. Additionally, Trump has signed an executive order aimed at vetting advanced AI models, while Novo Nordisk has launched its Wegovy pill in a new market outside the U.S.
- ▪Bitcoin (BTC-USD) is lagging behind equities amid record ETF outflows.
- ▪MSTR's first Bitcoin sale in nearly four years challenges its 'never sell' strategy.
- ▪Trump has signed an executive order for vetting advanced AI models.
- ▪Novo Nordisk (NVO) has launched the Wegovy pill in its first market outside the U.S.
Opening excerpt (first ~120 words) tap to expand
{"@context":"https://schema.org","@type":"NewsArticle","mainEntityOfPage":{"@type":"WebPage","@id":"https://seekingalpha.com/article/4911349-wall-street-breakfast-podcast-bitcoins-great-withdrawal"},"author":{"@type":"Person","name":"Wall Street Breakfast","url":"https://seekingalpha.com/author/wall-street-breakfast"},"publisher":{"@context":"http://schema.org","@type":"Organization","address":{"@type":"PostalAddress","streetAddress":"244 5th Ave","addressLocality":"New York","addressRegion":"NY","postalCode":"10001","addressCountry":"US"},"alternateName":["SeekingAlpha","SA"],"brand":[{"@type":"Brand","name":"Seeking Alpha Premium","url":"https://seekingalpha.com/subscriptions/premium"},{"@type":"Brand","name":"Seeking Alpha…
Excerpt limited to ~120 words for fair-use compliance. The full article is at Seeking Alpha.
Discussion
0 commentsMore from Seeking Alpha
